Industry: Medical Devices & Consumables
Published Date: 2024-10-23
Pages: 96 Pages
Report ld: 2112721
Request Sample
Customized Report
Transcranial Magnetic Stimulators (TMS) Market Size(US$)

CAGR 2024-2030
16%
Market Size,2030
USD 448
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
The global Transcranial Magnetic Stimulators (TMS) market was valued at US$ 161 million in 2023 and is anticipated to reach US$ 448 million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.
A key driver of the transcranial magnetic stimulator (TMS) market is the rising prevalence of mental health disorders, particularly treatment-resistant depression and anxiety. As traditional therapies like medication and psychotherapy prove ineffective for some patients, there is increasing demand for alternative, non-invasive treatment options such as TMS. Additionally, growing awareness of TMS as a safe and effective intervention, coupled with technological advancements that improve its accessibility and precision, is driving market growth. A major challenge in the TMS market is the high cost of equipment and treatment sessions, which can limit accessibility for both healthcare providers and patients. TMS devices are expensive, and the treatments often require multiple sessions, making it a costly option for patients, particularly those without insurance coverage. Furthermore, limited awareness and availability of TMS in certain regions, as well as the need for trained professionals to administer the treatment, can create additional barriers to market expansion.
Global key players of transcranial magnetic stimulators (TMS) include Yiruide, Magstim, Neuronetics, etc. China is the largest producer of fNIRS brain imaging system, holds a share about 40%, followed by North America, and Europe. In terms of product, rTMS is the largest segment, with a share over 55%. And in terms of application, the largest segment is psychopharmacology, with a share over 45%.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Transcranial Magnetic Stimulators (TMS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcranial Magnetic Stimulators (TMS).
The Transcranial Magnetic Stimulators (TMS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Transcranial Magnetic Stimulators (TMS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcranial Magnetic Stimulators (TMS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Yiruide
Neuronetics
Magstim
MagVenture
Neurosoft
Brainsway
eNeura
Remed
Nexstim
MAG & More
Jiangxi Brain Modulate
VISHEE
YINGCHI
Junjian Wanfeng
Segment by Type
rTMS
sTMS
pTMS
Others
Segment by Application
Psychopharmacology
Neurology
Rehabilitation Department
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transcranial Magnetic Stimulators (TMS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transcranial Magnetic Stimulators (TMS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Transcranial Magnetic Stimulators (TMS) Market Overview
1.1 Product Definition
1.2 Transcranial Magnetic Stimulators (TMS) by Type
1.2.1 Global Transcranial Magnetic Stimulators (TMS) Market Value Comparison by Type (2024-2030)
1.2.2 rTMS
1.2.3 sTMS
1.2.4 pTMS
1.2.5 Others
1.3 Transcranial Magnetic Stimulators (TMS) by Application
1.3.1 Global Transcranial Magnetic Stimulators (TMS) Market Value by Application (2024-2030)
1.3.2 Psychopharmacology
1.3.3 Neurology
1.3.4 Rehabilitation Department
1.3.5 Others
1.4 Global Transcranial Magnetic Stimulators (TMS) Market Size Estimates and Forecasts
1.4.1 Global Transcranial Magnetic Stimulators (TMS) Revenue 2019-2030
1.4.2 Global Transcranial Magnetic Stimulators (TMS) Sales 2019-2030
1.4.3 Global Transcranial Magnetic Stimulators (TMS) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transcranial Magnetic Stimulators (TMS) Market Competition by Manufacturers
2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transcranial Magnetic Stimulators (TMS) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Transcranial Magnetic Stimulators (TMS), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Product Type & Application
2.7 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Date of Enter into This Industry
2.8 Global Transcranial Magnetic Stimulators (TMS) Market Competitive Situation and Trends
2.8.1 Global Transcranial Magnetic Stimulators (TMS) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transcranial Magnetic Stimulators (TMS) Players Market Share by Revenue
2.8.3 Global Transcranial Magnetic Stimulators (TMS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transcranial Magnetic Stimulators (TMS) Market Scenario by Region
3.1 Global Transcranial Magnetic Stimulators (TMS) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2019-2030
3.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2019-2024
3.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2025-2030
3.3 Global Transcranial Magnetic Stimulators (TMS) Revenue by Region: 2019-2030
3.3.1 Global Transcranial Magnetic Stimulators (TMS) Revenue by Region: 2019-2024
3.3.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Region: 2025-2030
3.4 North America Transcranial Magnetic Stimulators (TMS) Market Facts & Figures by Country
3.4.1 North America Transcranial Magnetic Stimulators (TMS) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transcranial Magnetic Stimulators (TMS) Sales by Country (2019-2030)
3.4.3 North America Transcranial Magnetic Stimulators (TMS) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transcranial Magnetic Stimulators (TMS) Market Facts & Figures by Country
3.5.1 Europe Transcranial Magnetic Stimulators (TMS) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transcranial Magnetic Stimulators (TMS) Sales by Country (2019-2030)
3.5.3 Europe Transcranial Magnetic Stimulators (TMS) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Facts & Figures by Region
3.6.1 Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transcranial Magnetic Stimulators (TMS) Sales by Region (2019-2030)
3.6.3 Asia Pacific Transcranial Magnetic Stimulators (TMS) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transcranial Magnetic Stimulators (TMS) Market Facts & Figures by Country
3.7.1 Latin America Transcranial Magnetic Stimulators (TMS) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transcranial Magnetic Stimulators (TMS) Sales by Country (2019-2030)
3.7.3 Latin America Transcranial Magnetic Stimulators (TMS) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transcranial Magnetic Stimulators (TMS) Market Facts & Figures by Country
3.8.1 Middle East and Africa Transcranial Magnetic Stimulators (TMS) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transcranial Magnetic Stimulators (TMS) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transcranial Magnetic Stimulators (TMS) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Type (2019-2030)
4.1.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Type (2019-2024)
4.1.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Type (2025-2030)
4.1.3 Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Type (2019-2030)
4.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Type (2019-2030)
4.2.1 Global Transcranial Magnetic Stimulators (TMS) Revenue by Type (2019-2024)
4.2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Type (2025-2030)
4.2.3 Global Transcranial Magnetic Stimulators (TMS) Revenue Market Share by Type (2019-2030)
4.3 Global Transcranial Magnetic Stimulators (TMS) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Application (2019-2030)
5.1.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Application (2019-2024)
5.1.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Application (2025-2030)
5.1.3 Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Application (2019-2030)
5.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Application (2019-2030)
5.2.1 Global Transcranial Magnetic Stimulators (TMS) Revenue by Application (2019-2024)
5.2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Application (2025-2030)
5.2.3 Global Transcranial Magnetic Stimulators (TMS) Revenue Market Share by Application (2019-2030)
5.3 Global Transcranial Magnetic Stimulators (TMS) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Yiruide
6.1.1 Yiruide Company Information
6.1.2 Yiruide Description and Business Overview
6.1.3 Yiruide Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Yiruide Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.1.5 Yiruide Recent Developments/Updates
6.2 Neuronetics
6.2.1 Neuronetics Company Information
6.2.2 Neuronetics Description and Business Overview
6.2.3 Neuronetics Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Neuronetics Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.2.5 Neuronetics Recent Developments/Updates
6.3 Magstim
6.3.1 Magstim Company Information
6.3.2 Magstim Description and Business Overview
6.3.3 Magstim Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Magstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.3.5 Magstim Recent Developments/Updates
6.4 MagVenture
6.4.1 MagVenture Company Information
6.4.2 MagVenture Description and Business Overview
6.4.3 MagVenture Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MagVenture Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.4.5 MagVenture Recent Developments/Updates
6.5 Neurosoft
6.5.1 Neurosoft Company Information
6.5.2 Neurosoft Description and Business Overview
6.5.3 Neurosoft Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Neurosoft Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.5.5 Neurosoft Recent Developments/Updates
6.6 Brainsway
6.6.1 Brainsway Company Information
6.6.2 Brainsway Description and Business Overview
6.6.3 Brainsway Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Brainsway Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.6.5 Brainsway Recent Developments/Updates
6.7 eNeura
6.7.1 eNeura Company Information
6.7.2 eNeura Description and Business Overview
6.7.3 eNeura Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 eNeura Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.7.5 eNeura Recent Developments/Updates
6.8 Remed
6.8.1 Remed Company Information
6.8.2 Remed Description and Business Overview
6.8.3 Remed Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Remed Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.8.5 Remed Recent Developments/Updates
6.9 Nexstim
6.9.1 Nexstim Company Information
6.9.2 Nexstim Description and Business Overview
6.9.3 Nexstim Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nexstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.9.5 Nexstim Recent Developments/Updates
6.10 MAG & More
6.10.1 MAG & More Company Information
6.10.2 MAG & More Description and Business Overview
6.10.3 MAG & More Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MAG & More Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.10.5 MAG & More Recent Developments/Updates
6.11 Jiangxi Brain Modulate
6.11.1 Jiangxi Brain Modulate Company Information
6.11.2 Jiangxi Brain Modulate Description and Business Overview
6.11.3 Jiangxi Brain Modulate Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangxi Brain Modulate Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.11.5 Jiangxi Brain Modulate Recent Developments/Updates
6.12 VISHEE
6.12.1 VISHEE Company Information
6.12.2 VISHEE Description and Business Overview
6.12.3 VISHEE Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 VISHEE Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.12.5 VISHEE Recent Developments/Updates
6.13 YINGCHI
6.13.1 YINGCHI Company Information
6.13.2 YINGCHI Description and Business Overview
6.13.3 YINGCHI Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 YINGCHI Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.13.5 YINGCHI Recent Developments/Updates
6.14 Junjian Wanfeng
6.14.1 Junjian Wanfeng Company Information
6.14.2 Junjian Wanfeng Description and Business Overview
6.14.3 Junjian Wanfeng Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Junjian Wanfeng Transcranial Magnetic Stimulators (TMS) Product Portfolio
6.14.5 Junjian Wanfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transcranial Magnetic Stimulators (TMS) Industry Chain Analysis
7.2 Transcranial Magnetic Stimulators (TMS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transcranial Magnetic Stimulators (TMS) Production Mode & Process
7.4 Transcranial Magnetic Stimulators (TMS) Sales and Marketing
7.4.1 Transcranial Magnetic Stimulators (TMS) Sales Channels
7.4.2 Transcranial Magnetic Stimulators (TMS) Distributors
7.5 Transcranial Magnetic Stimulators (TMS) Customers
8 Transcranial Magnetic Stimulators (TMS) Market Dynamics
8.1 Transcranial Magnetic Stimulators (TMS) Industry Trends
8.2 Transcranial Magnetic Stimulators (TMS) Market Drivers
8.3 Transcranial Magnetic Stimulators (TMS) Market Challenges
8.4 Transcranial Magnetic Stimulators (TMS) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 210 million in 2025 and is forecast to reach a readjusted size of US$ 586 million by 2032 with a CAGR of 16.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 586 million by 2032, at a CAGR of 16.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 124
USD 2900.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 586 million, growing at a CAGR of 16.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 3950.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 97
USD 4250.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market is projected to grow from US$ 184 million in 2024 to US$ 512 million by 2031, at a CAGR of 16.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 167
USD 4900.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 129
USD 3950.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was valued at US$ 184 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 16.0% during the forecast period.
Published Date: 2025-02-07
Pages: 96
USD 2900.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 128
USD 4350.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 125
USD 3950.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 146
USD 4900.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 210 million in 2025 and is forecast to reach a readjusted size of US$ 586 million by 2032 with a CAGR of 16.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
The global Transcranial Magnetic Stimulators (TMS) market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 586 million by 2032, at a CAGR of 16.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 124
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 586 million, growing at a CAGR of 16.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 97
The global Transcranial Magnetic Stimulators (TMS) market is projected to grow from US$ 184 million in 2024 to US$ 512 million by 2031, at a CAGR of 16.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 167
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 129
The global market for Transcranial Magnetic Stimulators (TMS) was valued at US$ 184 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 16.0% during the forecast period.
Published: 2025-02-07
Pages: 96
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 128
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 125
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 146
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now